Brachytherapy device developer Xoft has launched a multicenter skin cancer trial for its Axxent eBx electronic brachytherapy system.
The trial aims to further prove the safety and feasibility of the device for the treatment of nonmelanoma skin cancers, according to the Sunnyvale, CA-based vendor. The first skin cancer patients were recently treated using Axxent, which has been available for the treatment of early-stage breast cancer since 2005 and for endometrial cancer since 2008, Xoft said.
Related Reading
Xoft wins Wisconsin install, July 24, 2009
Xoft receives Canadian approval for Axxent, April 9, 2009
FDA clears Xoft treatment applicator, March 5, 2009
Xoft's Axxent used in IORT procedure, October 1, 2008
Rhode Island Hospital uses Axxent for endometrial cancer, September 29, 2008
Copyright © 2009 AuntMinnie.com
